Status: Recruiting
Plexaa For Preconditioning: Gender Affirming Mastectomy
The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy. This study aims to understand a participant's experience of the device, including its usability and acceptability. Participants will use the device to precondition their right breast the evening before undergoing surgery (gender affirming mastectomy).
Participants needed: 15
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Plexaa LtdUpdated: Oct 1, 2025Locations: 1
Eligibility criteria
All transgender or non-binary patients over the age of 18 years (no maximum age... [+1]
Patients undergoing surgery for breast cancer [+4]